NASDAQ : DCTH
Delcath Systems, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 14.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 507.99M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 487.17M |
| Enterprise Value | 393.73M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 34.70M |
| Shares Outstanding | 34.70M |
| Shares Change (YoY) | +13.16% |
| Shares Change (QoQ) | +10.38% |
| Owned by Insiders (%) | 7.17% |
| Owned by Institutions (%) | 41.46% |
| Float | 25.52M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 955.10 |
| Forward PE | n/a |
| PS Ratio | 5.11 |
| Forward PS | 4.05 |
| PB Ratio | 4.01 |
| P/TBV Ratio | 4.02 |
| P/FCF Ratio | 27.83 |
| P/OCF Ratio | 24.87 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 740.10 |
| EV / Sales | 4.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 22.49 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.83 |
| Quick Ratio | 8.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 0.47% |
| Return on Assets (ROA) | -0.89% |
| Return on Invested Capital (ROIC) | -2.87% |
| Return on Capital Employed (ROCE) | -1.47% |
| Weighted Average Cost of Capital (WACC) | 7.50% |
| Revenue Per Employee | $611,654 |
| Profits Per Employee | $3,410 |
| Employee Count | 156 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.11 |
Taxes
| Measure | Value |
|---|
| Income Tax | 760,000 |
| Effective Tax Rate | 58.82% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +44.44% |
| 50-Day Moving Average | 15.66 |
| 200-Day Moving Average | 12.34 |
| Relative Strength Index (RSI) | 37.28 |
| Average Volume (20 Days) | 294,498 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.88M |
| Short Previous Month | 1.95M |
| Short % of Shares Out | 5.43% |
| Short % of Float | 7.38% |
| Short Ratio (days to cover) | 5.62 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 95.42M |
| Gross Profit | 83.06M |
| Operating Income | -1.81M |
| Pretax Income | 1.29M |
| Net Income | 532,000 |
| EBITDA | -1.46M |
| EBIT | -1.81M |
| Earnings Per Share (EPS) | $0.01 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 95.90M |
| Total Debt | 2.46M |
| Net Cash | 93.44M |
| Net Cash Per Share | $2.69 |
| Equity (Book Value) | 121.15M |
| Book Value Per Share | 3.50 |
| Working Capital | 117.26M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 19.59M |
| Capital Expenditures | -2.08M |
| Depreciation & Amortization | 359,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 17.51M |
| FCF Per Share | $0.50 |
Margins
| Measure | Value |
|---|
| Gross Margin | 87.05% |
| Operating Margin | -1.90% |
| Pretax Margin | 1.35% |
| Profit Margin | 0.56% |
| EBITDA Margin | -1.52% |
| EBIT Margin | -1.90% |
| FCF Margin | 18.35% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.16% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.10% |
| FCF Yield | 3.59% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $24.00 |
| Price Target Difference | 70.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 22.61% |
| EPS Growth Forecast (3Y) | 59.56% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:700.04 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 10.04 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |